Newsroom

NEW YORK--(BUSINESS WIRE)--Nuveen Churchill Direct Lending Corp. (NYSE: NCDL) (“NCDL” or the “Company”), a business development company externally managed by its investment adviser, Churchill DLC Advisor LLC (the “Adviser”), and by its sub-adviser, Churchill Asset Management LLC (“Churchill”), today reported financial results for the third quarter ended September 30, 2026. Financial Highlights and Recent Developments for the Quarter Ended September 30, 2026 Net investment income of $0.38 per sh...

SALT LAKE CITY--(BUSINESS WIRE)--Solen Software Group, a permanent capital partner to mission-critical software companies, today announced an investment partnership with Teletask Inc., the two-way messaging platform that WIC (Special Supplemental Nutrition Program for Women, Infants, and Children) and public health agencies use to reach families by text, voice, and email. Teletask supports public health agencies in more than 35 states, including WIC agencies serving over three million participan...

SAN DIEGO--(BUSINESS WIRE)--Gildan Activewear Inc. faces allegations that it failed to disclose that it had inadequate internal controls and was channel stuffing....

BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — a leading precision medicine diagnostics company in transplant, specialty oncology, and cell therapy, today announced the publication of a new analysis from the Kidney Allograft Outcomes AlloSure Registry (KOAR), a landmark multicenter study, in the journal Transplantation. The third manuscript from KOAR investigated the correlation between early post-transplant AlloSure Kidney donor-derived cell-free DNA (dd-cfDNA) levels and thr...

DUBLIN--(BUSINESS WIRE)--Alkermes plc (Nasdaq: ALKS) today reported financial results for the quarter ended September 30, 2026. To view the detailed third quarter 2026 earnings press release and presentation, please visit the company’s investor relations website at https://investor.alkermes.com. Alkermes will host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m. GMT) today, to discuss these financial results and provide an update on the company. The webcast may be accessed...

FAIRFAX, Va.--(BUSINESS WIRE)--Everforth ECS Secures NGA Contract Extension With Potential Value Exceeding $200M, Advancing Operational GEOINT Capabilities...

BOSTON & SAN DIEGO--(BUSINESS WIRE)--Elucid, an innovator of AI-powered cardiovascular imaging software, today announced results from ELUCIDATE, presented at the annual Transcatheter Cardiovascular Therapeutics Conference (TCT 2026). The ELUCIDATE study, which supported Elucid’s recent U.S. Food and Drug Administration (FDA) 510(k) clearance of the FFR-IQTM software, demonstrated 92.9 percent vessel-level diagnostic accuracy for Elucid’s FFR-IQ technology versus invasive fractional flow reserve...

HERNDON, Va.--(BUSINESS WIRE)--Sophia Learning announces a new partnership with Rocky Mountain College of Art + Design....

BURLINGAME, Calif.--(BUSINESS WIRE)--Upstart Publishes October 2026 Originations and Latest UMI...

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today reported financial results for the third quarter ended September 30, 2026, and provided a business update. “We entered 2026 with a clear plan to deliver multiple important clinical and operational milestones this year and we have made significant progress exec...